GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Artivion Inc (NYSE:AORT) » Definitions » LT-Debt-to-Total-Asset

Artivion (Artivion) LT-Debt-to-Total-Asset : 0.46 (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Artivion LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Artivion's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.46.

Artivion's long-term debt to total assets ratio declined from Mar. 2023 (0.46) to Mar. 2024 (0.46). It may suggest that Artivion is progressively becoming less dependent on debt to grow their business.

Artivion LT-Debt-to-Total-Asset Historical Data

The historical data trend for Artivion's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artivion LT-Debt-to-Total-Asset Chart

Artivion Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.39 0.39 0.45 0.46 0.45

Artivion Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.45 0.45 0.45 0.46

Artivion LT-Debt-to-Total-Asset Calculation

Artivion's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )/Total Assets (A: Dec. 2023 )
=352.913/792.397
=0.45

Artivion's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )/Total Assets (Q: Mar. 2024 )
=359.133/784.007
=0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artivion  (NYSE:AORT) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Artivion LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Artivion's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Artivion (Artivion) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Artivion Inc (NYSE:AORT) » Definitions » LT-Debt-to-Total-Asset
Comparable Companies
CATX AVNS SILK CTKB KIDS SSII FNA AHCO QTRX VREX ABT SYK BSX MDT XTER:SHL EW DXCM SZSE:300760 XAMS:PHIA ZBH
Traded in Other Exchanges
CYL:Germany
Address
1655 Roberts Boulevard North West, Kennesaw, GA, USA, 30144
Website
https://www.artivion.com
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.
Executives
Jean F Holloway officer: VP, General Counsel C/O ARTIVION INC, 1655 ROBERTS BLVD, KENNESAW GA 30144
John E Davis officer: Senior VP, Global Sales 1655 ROBERTS BLVD., NW, KENNESAW GA 30144
Amy Horton officer: Chief Accounting Officer C/O CRYOLIFE, INC., 1655 ROBERTS BLVD., NW, KENNESAW GA 30144
Florian Tyrs officer: VP, Global Operations IM SOELLER 3, BALINGEN 2M 72336
Robert C Thomson officer: VP Research & Development 33 HABERSHAM COVE DRIVE, NW, ATLANTA GA 30305
Matthew A Getz officer: VP, Human Resources 1655 ROBERTS BLVD NW, KENNESAW GA 30144
Dennis B Maier officer: Vice President, Operations 1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Rochelle L. Maney officer: VP, Quality 1655 ROBERTS BLVD, NW, KENNESAW GA 30144
James P Mackin officer: President & CEO ARTIVION, INC., 1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Marshall S. Stanton officer: SVP, Clinical & MD Affair 1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Andrew M Green officer: VP Regulatory ARTIVION INC, 1655 ROBERTS BLVD, KENNESAW GA 30144
David Ashley Lee officer: Executive VP, COO & CFO C/O CRYOLIFE INC, 1655 ROBERTS BLVD NW, KENNESAW GA 30144
Elizabeth A Hoff director 2701 WESTHEIMER ROAD, UNIT 1-E, HOUSTON TX 77098
Anthony B. Semedo director 3288 HARRISON GRADE ROAD, SEBASTOPOL CA 95472
Ronald D Mccall director C/O CRYOLIFE, INC., 1655 ROBERTS BOULEVARD, NW, KENNESAW GA 30144